Hanson R F
J Clin Invest. 1971 Oct;50(10):2051-5. doi: 10.1172/JCI106698.
The formation and metabolism of a naturally occurring C(27) bile acid, 3alpha,7alpha-dihydroxy-5beta-cholestan-26-oic acid, was studied in patients with T-tube bile fistulas. C-26-cholesterol-(14)C was shown to be converted to this C(27) bile acid. After synthesis and labeling with tritium, 3alpha,7alpha-dihydroxy-5beta-cholestan-26-oic acid was efficiently metabolized to chenodeoxycholic acid. After oral and i.v. administration there was conversion of about 80% of the administered amount to chenodeoxycholic acid. A small amount, less than 2% of the administered radioactivity, was converted to cholic acid. The remainder of the radioactivity was excreted in two unidentified peaks of radioactivity. The results of this study demonstrate that 3alpha,7alpha-dihydroxy-5beta-cholestan-26-oic acid is a metabolic product of cholesterol and is further metabolized, predominantly to chenodeoxycholic acid and to a minor extent to cholic acid in man.
在患有T型管胆汁瘘的患者中研究了天然存在的C(27)胆汁酸3α,7α-二羟基-5β-胆甾烷-26-酸的形成和代谢。结果表明,C-26-胆固醇-(14)C可转化为这种C(27)胆汁酸。用氚合成并标记后,3α,7α-二羟基-5β-胆甾烷-26-酸可有效代谢为鹅去氧胆酸。口服和静脉注射后,约80%的给药量转化为鹅去氧胆酸。少量(不到给药放射性的2%)转化为胆酸。其余放射性以两个未鉴定的放射性峰排出。本研究结果表明,3α,7α-二羟基-5β-胆甾烷-26-酸是胆固醇的代谢产物,在人体内进一步代谢,主要转化为鹅去氧胆酸,少量转化为胆酸。